Why is CYBERDYNE, Inc. ?
- The company has reported losses. Due to this company has reported negative ROE
- Poor long term growth as Operating profit has grown by an annual rate 0.99% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -113.14
- The company has reported losses. Due to this company has reported negative ROE
- NET SALES(Q) At JPY 953 MM has Fallen at -21.56%
- INTEREST(Q) At JPY 17 MM has Grown at inf%
- RAW MATERIAL COST(Y) Grown by 15.13% (YoY)
- Over the past year, while the stock has generated a return of 23.50%, its profits have risen by 95%
- The stock has generated a return of 23.50% in the last 1 year, much lower than market (Japan Nikkei 225) returns of 59.79%
How much should you hold?
- Overall Portfolio exposure to CYBERDYNE, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is CYBERDYNE, Inc. for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at JPY 195 MM
Highest at 0.39%
At JPY 221 MM has Grown at 138.04%
Highest at JPY 18,188 MM
Lowest at -21.51 %
At JPY -37 MM has Grown at 80.83%
At JPY 953 MM has Fallen at -21.56%
At JPY 17 MM has Grown at inf%
Grown by 15.13% (YoY
Lowest at 2.03 times
Lowest at 5.85 times
Lowest at -30.85 %
Here's what is working for CYBERDYNE, Inc.
Operating Cash Flows (JPY MM)
Pre-Tax Profit (JPY MM)
Net Profit (JPY MM)
Cash and Cash Equivalents
Debt-Equity Ratio
Here's what is not working for CYBERDYNE, Inc.
Net Sales (JPY MM)
Interest Paid (JPY MM)
Operating Profit to Sales
Inventory Turnover Ratio
Debtors Turnover Ratio
Raw Material Cost as a percentage of Sales






